Nusbickel Thomas 4
4 · CorMedix Inc. · Filed May 20, 2021
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Nusbickel Thomas
EVP, Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy Common Stock)
2021-05-13+7,500→ 7,500 totalExercise: $7.56Exp: 2031-05-13→ Common Stock (7,500 underlying) - Award
Stock Option (Right to Buy Common Stock)
2021-05-13+260,000→ 260,000 totalExercise: $7.56Exp: 2031-05-13→ Common Stock (260,000 underlying)
Footnotes (2)
- [F1]The options vest as follows: 160,000 will vest over four years in four (4) equal installments on the first four anniversaries of May 13, 2021. The remaining 100,000 options vest on the achievement of certain milestones, subject to continued employment.
- [F2]These options were granted on May 13, 2021. These options shall vest in full on the first anniversary of the grant date, subject to continued employment.